Week of Events
Seminar: Cis- and Trans-Regulatory Logics of Blood Stem Cells and Cancer
Seminar: Cis- and Trans-Regulatory Logics of Blood Stem Cells and Cancer
Jian Xu, PhD, UT Southwestern University
Seminar: David Toczyski, UCSD
Fall Blood Drive
Fall Blood Drive
With the help of our friends at the American Red Cross, donations will occur all day in the 2nd floor lobby of Kerr Hall. Please help us reach our goal! Snacks will be provided for donors. To make an appointment, sign up … Read more
Seminar: “Inhibition of Chromatin Binding Domains for the Treatment of Disease”
Seminar: “Inhibition of Chromatin Binding Domains for the Treatment of Disease”
Emily Dykhuizen (Purdue University)
Dr. Christopher Williams (Xavier University) Lecture CK2 as a key regulator of Estrogen Receptor alpha signaling in breast cancer.
Dr. Christopher Williams (Xavier University) Lecture CK2 as a key regulator of Estrogen Receptor alpha signaling in breast cancer.
Dr. Williams, Chair, Department of Pharmaceutical Sciences at Xavier University will be giving a lecture which is open to all UNC Eshelman School of Pharmacy Faculty and others, especially the UNC School of Medicine, entitled: CK2 as a key regulator … Read more
Seminar: “Mechanisms of transcriptional regulation through diverse coactivators”
Seminar: “Mechanisms of transcriptional regulation through diverse coactivators”
Robert G. Roeder, PhD, Arnold and Mabel Beckman Professor Biochemistry and Molecular Biology, the Rockefeller University
Andrew S Rachlin UNC Neuroscience Symposium: “Neuropsychiatric genetics meets the non-coding genome”
Andrew S Rachlin UNC Neuroscience Symposium: “Neuropsychiatric genetics meets the non-coding genome”
Keynote speakers Dan Geschwind and Flora Vaccarino. Also speakers from UNC, Duke, and NC State. It will be of broad interest to the genetics and neuroscience communities RSVP on website
Seminar: “Breast SPORE: The Development of CDK 4/6 Inhibitors in Breast Cancer”
Seminar: “Breast SPORE: The Development of CDK 4/6 Inhibitors in Breast Cancer”
Richard Finn, MD, Professor of Clinical Medicine, Jonsson Comprehensive Cancer Center, Geffen School of Medicine at UCLA